Adult hematopoietic and other tissue stem cells have highly constrained cell cycling that limits their susceptibility to standard gene therapy vectors, which depend upon chromosomal integration. Using cytokine cocktails to increase transduction efficiency often compromises subsequent stem cell function in vivo. We previously showed that p21
Introduction
Increasing the efficiency of gene transduction and maintaining the multipotentiality of stem/progenitor cells remain as a major challenge in application of gene therapy. Previous transduction methods have involved the use of cytokine cocktails to increase transduction efficiency. However, the increased efficiency occurs at the expense of multipotentiality of transduced stem/progenitor cells. [1] [2] [3] [4] Furthermore, clinical trials reveal an extremely low level of cells retaining the transduced genes post-transplantation. 5, 6 In this study, we used RNAi technology to silence a cell cycle checkpoint protein, p21
Waf1Cip1/Sdi1 (hereafter p21), in hematopoietic stem/progenitor cells. We show that silencing a single cell cycle checkpoint protein, p21, increased the gene transduction efficiency while retaining the multipotentiality of stem/progenitor cells. The increased transduction efficiency correlated with the increase of gene transfer-vector integration into the host cell genome.
Gene therapy vectors with the greatest promise for transduction of quiescent hematopoietic stem cells (HSC) are lentivectors. [7] [8] [9] [10] While lentivectors are less cell cycle dependent than murine retrovirus derived vectors, highly efficient gene transduction is correlated with the transition of quiescence (G 0 ) into cycle state (G 1 ) of cells. 1, 8, 11 We previously showed that p21 is a regulator of HSC quiescence and could be manipulated to alter stem cell kinetics. 18, 19 In this study, we knocked down p21 expression by using RNAi techniques. We not only increased the gene transduction efficiency but also retained the multipotential characteristics of transduced cells. Further, a transient silence of p21 expression increased lentivector integration into the host cell genome.
Results
P21siRNA knocked down p21 expression in CD34 + cells Two types of RNAi were generated to silence p21 expression in target cells. These were in vitro synthesized duplex siRNA and in vivo expressed plasmid-derived short hairpin RNA (shRNA). The effects of silencing p21 were studied in primary human CD34 + hematopoietic stem/progenitor cells and CMK cells derived from a human megakaryoblastic cell line. 12 Both types of siRNA knocked down p21 expression by 85-98% as measured with p21 mRNA copy number using a Taqman real time RT-PCR assay. A mismatched mutant siRNA (Si-2M) served as a specificity control and did not affect p21 expression (Figure 1a, b) . Further, the sequences on p21 targeted by the two types of siRNA were unique and nonoverlapping (Figure 1a) . The RNAi effect on mRNA levels observed was confirmed by reduced p21 protein levels as demonstrated by Western blot (Figure 1c) .
Next, we evaluated the duration effect of siRNA on p21 expression levels. For synthesized siRNA, the level of p21 mRNA returned to baseline at 10-15 days postsiRNA treatment and for transcribed shRNA derived from the plasmid, the level of p21 mRNA was back to the presilencing level at 22-28 days post-treatment ( Figure 1d ).
Silencing p21 expression increased the efficiency of gene transduction
To assess whether silencing p21 expression in stem/ progenitor cells increases the transduction efficiency, we used pHIvec2.GFP, a third generation lentivector, to examine the efficiency of gene transduction in primitive primary hematopoietic cells post-siRNA treatment [7] [8] [9] [10] 27, 28 ( Figure 2a ). Treating cells with p21 siRNA (Si-2) resulted in a reproducible two-to four-fold increase in lentiviral transduction as assessed by detection of green fluorescent protein (GFP) on flow cytometry (Figure 2b ). The magnitude of vector transduction efficiency compares favorably with other studies. 1, 3 To determine whether the effect on gene transduction could be assessed in marrow-reconstituting cells, we transplanted sublethally irradiated NOD/SCID mice with human CD34 + cells that had been exposed to lentivector with or without prior exposure to the siRNAs. A seven-to eight-fold increase of GFP + cells in mouse bone marrow (BM) was detected in animals transplanted with CD34 + cells treated with p21 specific siRNA 6 weeks following transplantation (Figures 2c and 3c ).
Silencing p21 increased transduction efficiency without losing cell multipotentiality
To evaluate whether treatment altered the proliferation and differentiation abilities of CD34 + cells, we assessed these cells in vitro and in vivo. Cells cultured for 22 days demonstrated similar low levels of CD34 expression that was not different in siRNA treated cells compared to control cells (Figure 3a ). Cells treated with p21siRNA and transduced with lentivector were plated in LTC-IC assays and yielded comparable to increased numbers of LTC-IC in contrast to siRNA mock-treated (Figure 3b) .
To evaluate the impact of siRNA treatment on cell proliferation and differentiation abilities in vivo, CD34 
Discussion
RNAi is a powerful technique to silence gene expression and it has changed the study of target gene regulation and phenotypic alteration in the cells previously found refractory to gene manipulations. [15] [16] [17] In this study, we used two types of siRNA specific for p21 to silence p21 expression in CD34 + hematopoietic stem/progenitor cells and to enhance gene transduction efficiency. Our data show that silencing p21 not only increased the efficiency of gene transduction in CD34 + hematopoietic stem/progenitor cells but also preserved the multipotentiality of these cells. The effect of silencing p21 expression in target cells was transient while allowing a stable integration of gene transfer-vector into the cellular genome. Silencing p21 in a transient manner by siRNA is appealing because it limits the potential for permanent p21 deficiency contributing to malignant transformation. This may provide an advantage for stem cells treated by siRNA in gene therapy application.
Hematopoietic stem/progenitor cells are a rare population of cells. We used two types of cells to examine the effect of silencing p21 expression in hematopoietic stem and progenitor cells: the primitive BM CD34 + cells and the human megakaryoblastic cells from CMK cell line. 12 After silencing p21, the transduction efficiency with pHIvec2.GFP was reproducibly increased two-to fourfold in both BM CD34 + cells and in CMK cells as determined in cell culture assays. When the p21siRNA treated cells transduced with pHIvec2.GFP were transplanted into NOD/SCID mice, the efficiency of gene transduction was increased to seven-to eight-fold, Silencing p21 increasing transduction efficiency J Zhang et al assessed by GFP + cells in mouse BM. These data show that p21, a principle cell cycle checkpoint protein in HSC, 18, 19 can be harnessed to increase gene transduction efficiency in HSC without compromising cell repopulation ability.
The effect of siRNA treatment on the proliferation and differentiation abilities of CD34 + cells was evaluated in vitro and in vivo. First, we determined that CD34 + cells post-siRNA treatment retained to be CD34 positive were not different from control cells. Second, these cells + cells treated by p21siRNA transduced with the lentivector, generated seven-to eight-fold more GFP + cells in bone marrow than in the control mouse (HPRT). The mean value of GFP + cells detected is shown in Figure 3c . Others have reported that reducing the levels of both TGF-b and p27 kip-1 (p27) increases the retroviral transduction of primitive human hematopoietic cells. 20 Both reductions in TGF-b with an antibody and p27 with antisense oligonucleotides were needed to increase the retroviral transduction and the progenitor cell expansion that occurs with cells treated by Anti-p27 may complicate analysis of transduction efficiency. 20 The system we employed here indicates that an siRNA method of transiently silencing p21 provides a relatively simple method for ex vivo manipulation and gene transduction of hematopoietic stem/progenitor cells. We tested both transient and stable transduction efficiencies by examination of a lentivector derived GFP gene expression in target cells at post-transduction 16-72 h in cell cultures and at 45 days in NOD/SCID mice. We directly detected the transduction efficiency by determining that the transduced gene was functionally expressed in transduced target cells by detecting GFP + cells in cultures and in mice. The level of lentivector integration was assessed by a real time, quantitative Alu-LTR PCR assay. A magnitude increase of integrated vector was detected in p21siRNA treated cells but not in control siRNA treated cells. Together, our data demonstrate that silencing p21, a single cell cycle checkpoint protein, increased the gene transduction efficiency in both transient and stable manners.
Our previous studies have shown that in the absence of p21, HSC proliferate under normal homeostatic conditions while expanding stem cell pool size. 18, 19 In this study, transiently silencing p21 expression in CD34 
Materials and methods

Generation of siRNA
The p21siRNA duplexes were selected from nucleotide sequences X100 bp downstream of AUG codon of human p21 gene. 21 The mismatched p21siRNA (Si-2M) has a four-base pair mismatch from the wild-type p21 sequence. All siRNAs were synthesized by Dharmacon Research (Lafayette, CO, USA) using 2 0 -ACE protection chemistry. The synthetic siRNA duplexes were deprotected according to the manufacturer's instruction. The plasmids that contain DNA templates encoding p21shRNA in cells were constructed by insertion of a 64-bp DNA fragment into the ApaI and EcoR1 site of plasmid pU6/BS (a gift from Dr Y Shi 22, 23 ). All the DNA fragments consist of 23 bases of sense and antisense of human p21 cDNA sequences separated with a 6 bpspacer. The shRNA is transcribed by the RNA polymerase III promoter, U6, and forms a duplex plus a hairpin in the targeted cells. 22, 23 The shRNA sequences inserted into the plasmid do not overlap with the in vitro synthetic siRNA duplexes described above. The constructed plasmids that encode p21 shRNA were transformed into Escherichia coli and selected by the blue colonies resistant to ampicillin.
Transfer siRNA and shRNA into cells
The siRNA and plasmids encoding shRNA were purified by phenol/chloroform/isoamylalcohol extraction and ethanol precipitation. The purified siRNA was transfected into BM CD34 + stem/progenitor cells with siPort method (Ambion, Austin, TX, USA), following the manufacturer's instructions. The purified siRNA and 
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Silencing p21 increasing transduction efficiency J Zhang et al DNA encoding siRNA were also suspended in the electroporation buffer, and electroporated into human megakaryoblastic leukemia cells (CMK) in a log growth phase. The electroporation procedure is as previously described with a minor modification. 24 The transfected cells were resuspended in 10% FBS PRMI media for 48-60 h before harvest to examine p21 mRNA and protein expression in these cells. The cell aliquots from a same assay were used for detection of either p21 mRNA or protein expression after the RNAi treatment.
Real time RT-PCR assay
Assay was performed as previously described. 19 Briefly, the sequences of the primer set for detection of human p21 mRNA were as follows: p21 forward: 5 0 -AATCCC AGCTACTTGGAAGGC-3 0 ; p21 reverse: 5 0 -GCTGACTG CAACCTCTGCC-3 0 ; and p21 probe:
0 . Human cellular GAPDH mRNA was used as the endogenous control in each RT-PCR reaction, and the primers and probe were from TaqMan GAPDH Control Reagent kit (PE Biosystems, Foster City, CA, USA). The total cellular RNA from cells was isolated with the RNeasy kit (Qiagen, Valencia, CA, USA) and purified with DNase following the RNeasy clean up protocol (Qiagen, Valencia, CA, USA). An equal amount of purified RNA (50 ng) in triplicate from each sample was examined in each experiment. A standard curve of the amplicon being measured was run in duplicate range from 1 to 1 Â 10 10 copies in each assay, with two none-template controls. The amplicons from each reaction were analyzed using the Sequence Detector V1.7 software. The RNA copy number in each sample was converted according to the standard curve as well as the C T value of the amplicons from each sample.
Western blot analysis
The extract of whole cellular protein was prepared from 10 6 cells for each assay condition. The cells were washed and lysed with the lysis buffer. The concentration of protein was titrated with a BCA protein assay (Pierce, Woburn, MA, USA). Sample proteins were separated on 16% SDS-PAGE gel (Invitrogen, Carlsbad, CA, USA). The p21 protein extracted from the mammalian cell nucleus (Santa Cruz Biotech, Santa Cruz, CA, USA) and the protein size standard (Bio-Rad, Philadelphia, PA, USA) were included in each gel, serving as positive control and molecular weight controls, respectively. After the separation, the proteins were transferred onto the nitrocellulose membrane (Amersham, Piscataway, NJ, USA). The transferred membrane was blocked with 5% milk for overnight, then detected with a primary antibody, the mouse-anti-human p21 monoclonal antibody (Santa Cruz, Biotech, Santa Cruz, CA, USA). The second antibody was an HRP labeled rabbit anti-mouse IgG (Jackson Immuno, West Grove, PA, USA). The image was obtained by immediately exposing the membrane to film for 30 s-10 min. + cells were enriched by immunomagnetic selection according to the manufacturer's instructions (Miltenyi Biotec, Auburn, CA, USA) with a purity in the selected product of 96% consistently. The CD34 + progenitor cells were cultured in StemSpan media (StemCell Technologies, Canada) supplemented with 300 ng/ml stem cell factor (SCF), Flt-3-ligand (Flt-3-L), and 60 ng/ml interleukin-3 (IL-3) (R&D Systems, Minneapolis, MN, USA) at 371C under 5% CO 2 . 25, 26 Human megakaryoblastic leukemia cells (CMK) were grown in RPMI with 20% fetal bovine serum (FBS) and cells in log growth were used in the experiment. P21 expression in CMK cells is in a p53-independent manner. 12 The lentivector pHIvec2.GFP is a gift from Dr Joseph Sodroski and generation of lentivirus followed the protocol as previously described. 27, 28 PHIvec2.GFP is capable of expressing GFP and is pseudotyped with the G glycoprotein from the vesicular stomatitis virus (VSV). This vector is derived from v653 rtatpC 23 by deleting env and vpu sequences, but leaving the Rev-responsive element (HXBc2 nucleotide positions 6094-7655) intact and by introduction of a BamHI-XbaI fragment containing the EGFP gene (Clontech) into HXBc2 positions 8474-8624.
Recombinant viruses were produced by cotransfection of 293T cells with pHIvec2.GFP, pCMVP1envpA, pHCMV-G, and a Rev-expressing plasmid in a 10:10:2:1 ratio. At 12 h after transfection, the medium was changed. Conditioned medium containing recombinant viruses was harvested and filtered (0.45-mm pore size) 24 h later. The viral pool was titrated with HIV-1 reverse transcription activity assay.
The transduction of lentivector to CD34 + cells was performed by culturing cells in above media for 42 h post-RNAi treatment. The cells were washed with media and transduced with pHIvec2.GFP at 3000 RTU per million cells followed a spin infection procedure. Cells were washed and resuspended in above media and cultured at 371C until examined for GFP expression.
Fluorescent activated cell sorter (FACS) analysis
The transduced CD34 + cells were examined for GFP expression at 66 h post-transduction with a FACSCalibur cytometer (Becton Dickinson). For detection of expressed human leukocyte cell markers, the cells were stained with anti-human antibodies purchased from Becton Dickinson and the stained cell samples were analyzed on a FACS-Calibur cytometer. The flow cytometry data were analyzed with the Cellquest software.
LTC-IC assay
The aliquots of RNAi treated, lentivector transduced cells were cultured on stromal cell layer in a 96-well plate with limiting dilution as previously described. 19 The LTC-IC were scored at the 7th week and the frequency was calculated with Maxrob software.
NOD/SCID repopulation assay
This assay was performed as previously described. 19 Briefly, NOD/SCID mice (Jackson Laboratories, Bar Harbor, ME, USA) were handled under sterile conditions and maintained under microisolaters. 
Statistical analysis
The significance of the difference between groups in the in vitro and in vivo experiments was evaluated by analysis of variance followed by a two-tailed Student's t-test, and confidence intervals were calculated at the 95% level. All the statistical analyses were performed using SAS version 8.1 software (SAS Institute, Inc., Cary, NC, USA).
Alu-LTR PCR assay
The Alu-LTR PCR assay [29] [30] [31] was used to examine the HIV-1 DNA integrated into the cellular genome. We adapted this assay with some modifications. Briefly, a nested PCR assay was carried out with two sets of Alu-LTR primers and a probe. The sequences of the primers for first step PCR were the same as that of Alu forward (MH535) and Alu reverse (SB704). 30 The PCR was performed by using Taq polymerase (Gibco BRL, Rockville, MD, USA) and a DNA thermal cycler (Perkin Elmer, Foster City, CA, USA). The viral DNA was detected from cellular genomic DNA in 5 Â 10 4 cells (500 ng) in each assay condition. The DNA samples were subjected to denaturation at 941C, 4 min, then 20 cycles of denaturation at 941C, 0.5 min, annealing at 551C, 0.5 min and extension at 721C, 3 min, with a last cycle extension at 721C, 7 min. Following the initial PCR, a second nested PCR amplification was carried out by using an aliquot equivalent to 1/20 of the 20-cycle PCR product, amplified with the second Alu-LTR primers and the probe. The second Alu-LTR PCR was a Taqman real time PCR assay. The sequences of the second set of primer and probe are as follows: Alu forward (3 0 of LTR) 5 0 -GGTAACTAGAGATCCCTCAGACCCT-3 0 ; Alu reverse (5 0 of Alu) 5 0 -GCGTGAGCCACCGC-3 0 ; and Alu probe 5 0 -TTAGTCAGTGTGGAAAATCTCTAGCAGGCC G-3 0 . The Taqman Alu-LTR PCR assay was performed as described before by using the second set of Alu-LTR primers and probe. 30 The integrated viral DNA was detected with four sets of standards and the two sets of primers and probes. A standard is derived from the known copy number of SM2 plasmid spiked with H9 cellular DNA. 30 In addition to the standards that are mentioned in the reference, 30 we added another standard that was prepared from the gel purified genomic DNA of OM10.1 cells. 29, 32 A copy number reference control derived from IS cell line (a gift from Dr O'Doherty) was also included in our assay, and served as a reference to calculate copy number for unknowns after the amplification. 31 The standard curve from these references was used for providing copy numbers derived from threshold cycles (C T value) that were p36 cycles 29, 33 with FAM (6-carboxyfluor-escein). 30 and the amplification conditions are the same as described. 29, 30 Each sample was tested in triplicate, and the copy number of viral DNA was read directly from the result report spreadsheet that is converted from C T value in the function of the standard curve with Sequence Detector V1.7 software.
